~~<i id='2BC8A63DF3'><strike id='2BC8A63DF3'><tt id='2BC8A63DF3'><pre id='2BC8A63DF3'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

leisure time

author：explore 2025-09-29 13:46:07 - browse：448

An advisory panel to the Food and Drug Administration delivered a split decision on a surgical system used in a controversial blood pressure treatment called renal denervation.

The panel, whose advice the FDA typically follows, voted that the system developed by ReCor Medical was safe and effective. It voted that the benefits of a system developed by Medtronic, however, did not outweigh the risks.

“While this is a very safe procedure, the efficacy was mild at best,” Keith Allen, director of surgical research at St. Luke’s Hospital of Kansas City, said regarding Medtronic’s device.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Hollywood unions extend contract negotiations for actors
Next article： 'The Exorcist' director William Friedkin dead at 87

hotspot

Wikipedia

explore

hotspot

knowledge

focus

0:27InvestigatorslookatrotorbladesfromoneofthecrashedhelicoptersonaburnedhillsideinCabazon,Calif.,on

WSS

Arizona Democrat to raise extreme heat with Biden 1 year out from Senate primary

Group opposing PBM reform sets lobbying record

NYC plans to house migrants on an island in the East River

Trump lawyer welcomes Pence testifying in Jan. 6 trial, won't say if Trump will too

Arizona Democrat to raise extreme heat with Biden 1 year out from Senate primary

Detailed data confirm benefits, risks of Eli Lilly's Alzheimer's drug

leisure time

leisure time

hotspot

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

In medicine, common shorthands can shortchange care

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Cosmetics set for new safety regulation. Why the industry is on board

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Thousands in Haiti march to demand safety from violent gangs as killings and kidnappings soar

FDA approval of Sarepta Duchenne genetic therapy gives me hope

The UK government moves asylum

Moonlake's readout produced a cash windfall. Risks remain

Sanofi seeks simpler, safer CRISPR sickle cell cure

Wikipedia

Democratic lawmaker calls for 'well

Trump Jan. 6 attorney John Lauro is ex

Rescued Australian man who was adrift 3 months in Pacific with dog 'grateful' to be alive

Moderna hits safety problems in bold bid to reinvent medicine

Boeing's 1st astronaut flight bumped into next year, more repairs needed

Why hospitals are withdrawing from US News rankings

explore

hotspot

knowledge

focus